Barclays Downgrades Biomea Fusion Stock, Cuts Price Target to $5

Friday, 7 June 2024, 08:57
In a significant move, Barclays downgraded Biomea Fusion stock and drastically reduced the price target from $30 to $5. This unexpected adjustment reflects a notable shift in the market sentiment towards Biomea Fusion, raising concerns among investors and analysts.
https://store.livarava.com/27935243-24fa-11ef-a412-9d5fa15a64d8.jpg
Barclays Downgrades Biomea Fusion Stock, Cuts Price Target to $5

Biomea Fusion Stock Downgraded by Barclays: Price Target Slashed to $5

In a significant move, Barclays downgraded Biomea Fusion stock and drastically reduced the price target from $30 to $5. This unexpected adjustment reflects a notable shift in the market sentiment towards Biomea Fusion, raising concerns among investors and analysts.

Do you want to advertise here? Contact us

Related posts

Do you want to advertise here? Contact us
Do you want to advertise here? Contact us
Newsletter

We carefully select news from the world of finance and publish it for our users. We understand the importance of reliable and up-to-date information for people in the financial world. Do you want to receive news in a convenient format and always have it at hand — subscribe to our newsletter and make your analytical work more effective.

Subscribe